Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam

NCT02082665 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: Rosuvastatin10 mg tablet
DRUG: Midazolam 3 mg syrup
DRUG: Dabrafenib 75 mg capsule

Sponsor

GlaxoSmithKline